Aki India Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
AKI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.1 pts more than Nifty Microcap 250 and 1.4 pts more than its Leather And Leather Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
AKI India reported a sharp divergence between its standalone and consolidated numbers for Q3 FY26 and 9M FY26. On a standalone basis, Q3 net sales fell sharply to ₹1,329.50 lakhs from ₹2,174.81 lakhs a year earlier (~39% decline), with PAT dropping to ₹18.93 lakhs from ₹66.97 lakhs and EPS at ₹0.02 vs ₹0.08. For 9M FY26 standalone, net sales declined to ₹4,303.87 lakhs (~17% lower) and PAT fell to ₹86.01 lakhs from ₹150.93 lakhs. However, on a consolidated basis (including subsidiary AKI UK Limited and joint venture AKI Castil Shoes LLP), 9M FY26 net sales grew to ₹7,074.88 lakhs from ₹5,694.18 lakhs (~24% growth) and PAT jumped to ₹210.00 lakhs from ₹154.42 lakhs (~36% growth), with EPS rising to ₹0.20 from ₹0.17. Standalone operating margins compressed meaningfully, while consolidated margins held broadly steady. The prior-year 9M figures included a positive exceptional/extraordinary item of ₹82.64 lakhs. Statutory auditor R K Parmarthi & Co. issued a clean limited review report with no qualifications or emphasis of matter.
Mixed bag for shareholders: standalone leather business is clearly under pressure with falling revenue and profits, but consolidated growth from subsidiaries/JV is strong, lifting overall earnings. Short-term stock reaction could be cautious given the steep standalone Q3 decline, though the consolidated growth story may support valuation if subsidiary momentum continues.